These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 26136339)
1. Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion. Pulito C; Mori F; Sacconi A; Casadei L; Ferraiuolo M; Valerio MC; Santoro R; Goeman F; Maidecchi A; Mattoli L; Manetti C; Di Agostino S; Muti P; Blandino G; Strano S Oncotarget; 2015 Jul; 6(20):18134-50. PubMed ID: 26136339 [TBL] [Abstract][Full Text] [Related]
2. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154 [TBL] [Abstract][Full Text] [Related]
3. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma. Kanteti R; Riehm JJ; Dhanasingh I; Lennon FE; Mirzapoiazova T; Mambetsariev B; Kindler HL; Salgia R Sci Rep; 2016 Sep; 6():32992. PubMed ID: 27623107 [TBL] [Abstract][Full Text] [Related]
4. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro. Hoda MA; Pirker C; Dong Y; Schelch K; Heffeter P; Kryeziu K; van Schoonhoven S; Klikovits T; Laszlo V; Rozsas A; Ozsvar J; Klepetko W; Döme B; Grusch M; Hegedüs B; Berger W Mol Cancer Ther; 2016 Oct; 15(10):2357-2369. PubMed ID: 27512118 [TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma. Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086 [TBL] [Abstract][Full Text] [Related]
6. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells. Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562 [TBL] [Abstract][Full Text] [Related]
7. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma. Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model. Abe S; Kaneko MK; Tsuchihashi Y; Izumi T; Ogasawara S; Okada N; Sato C; Tobiume M; Otsuka K; Miyamoto L; Tsuchiya K; Kawazoe K; Kato Y; Nishioka Y Cancer Sci; 2016 Sep; 107(9):1198-205. PubMed ID: 27294401 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells. Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320 [TBL] [Abstract][Full Text] [Related]
10. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts. Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918 [TBL] [Abstract][Full Text] [Related]
11. Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth Laszlo V; Valko Z; Kovacs I; Ozsvar J; Hoda MA; Klikovits T; Lakatos D; Czirok A; Garay T; Stiglbauer A; Helbich TH; Gröger M; Tovari J; Klepetko W; Pirker C; Grusch M; Berger W; Hilberg F; Hegedus B; Dome B Clin Cancer Res; 2018 Aug; 24(15):3729-3740. PubMed ID: 29724868 [No Abstract] [Full Text] [Related]
12. Preclinical demonstration of synergistic Active Nutrients/Drug (AND) combination as a potential treatment for malignant pleural mesothelioma. Volta V; Ranzato E; Martinotti S; Gallo S; Russo MV; Mutti L; Biffo S; Burlando B PLoS One; 2013; 8(3):e58051. PubMed ID: 23526965 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition. Quispel-Janssen JM; Badhai J; Schunselaar L; Price S; Brammeld J; Iorio F; Kolluri K; Garnett M; Berns A; Baas P; McDermott U; Neefjes J; Alifrangis C Clin Cancer Res; 2018 Jan; 24(1):84-94. PubMed ID: 29061644 [No Abstract] [Full Text] [Related]
14. Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma. Sage EK; Kolluri KK; McNulty K; Lourenco Sda S; Kalber TL; Ordidge KL; Davies D; Gary Lee YC; Giangreco A; Janes SM Thorax; 2014 Jul; 69(7):638-47. PubMed ID: 24567297 [TBL] [Abstract][Full Text] [Related]
15. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma. Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744 [TBL] [Abstract][Full Text] [Related]
16. Combination effect of photodynamic therapy using NPe6 with pemetrexed for human malignant pleural mesothelioma cells. Maehara S; Usuda J; Ishizumi T; Ichinose S; Ohtani K; Inoue T; Imai K; Furumoto H; Kudo Y; Kajiwara N; Ohira T; Ikeda N Int J Oncol; 2015 Feb; 46(2):741-9. PubMed ID: 25385189 [TBL] [Abstract][Full Text] [Related]
17. Ethyl acetate extract from Selaginella doederleinii Hieron inhibits the growth of human lung cancer cells A549 via caspase-dependent apoptosis pathway. Sui Y; Li S; Shi P; Wu Y; Li Y; Chen W; Huang L; Yao H; Lin X J Ethnopharmacol; 2016 Aug; 190():261-71. PubMed ID: 27292193 [TBL] [Abstract][Full Text] [Related]
18. Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells. Manente AG; Pinton G; Zonca S; Cilli M; Rinaldi M; Daga A; Nilsson S; Moro L Oncotarget; 2015 Sep; 6(28):25121-34. PubMed ID: 26208479 [TBL] [Abstract][Full Text] [Related]
19. SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells. Pinton G; Zonca S; Manente AG; Cavaletto M; Borroni E; Daga A; Jithesh PV; Fennell D; Nilsson S; Moro L Oncotarget; 2016 Mar; 7(12):14366-79. PubMed ID: 26885609 [TBL] [Abstract][Full Text] [Related]
20. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro. You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]